Operator
Operator
Good morning, ladies and gentlemen, and welcome to the Church & Dwight Second Quarter 2016 Earnings Conference Call. Before we begin, I have been asked to remind you that on this call, the company's management may make forward-looking statements regarding, among other things, the company's financial objectives and forecasts. These statements are subject to risk and uncertainties and other factors that are described in detail in the company's SEC filings. I would now like to introduce your host for today's call, Mr. Matt Farrell, Chief Executive Officer of Church & Dwight. Please go ahead, sir. Matthew T. Farrell - President & Chief Executive Officer: Good morning, everyone. Thanks for joining us for today. I'm going to start with a brief review of our second quarter results, which you read about in today's press release. I'll then say a few words about our categories before I turn the call over to Rick Dierker. Rick will comment on each of our businesses and review the outlook for Q3 and the full year. And when Rick is finished, I'll get back on and we'll open the call up for questions. So here are the highlights; Q2 was a terrific quarter for our company. We posted organic sales growth of 3.7% and 16.4% EPS growth, which is 17.8% EPS growth on a currency neutral basis. Category growth was broad-based, in that nine of our 15 categories grew in the quarter. From a market share perspective four of our 10 power brands grew share. Now I'll comment on a few of our categories; that would be laundry, litter, vitamins and dry shampoo. The laundry category continues to be healthy, growing 2.5% year-over-year. This is the fifth quarter in a row of laundry category growth. The value segment grew 4%, led by ARM & HAMMER, Simply Tide and Sun, mid and premium tier segments grew slower than the category. The Laundry category growth was driven by both the unit dose and liquid segments. Now I'll comment on our three laundry brands. ARM & HAMMER has been our big franchise in laundry for many years. ARM & HAMMER laundry share continued to grow this quarter, up 10 basis points. To illustrate the consistency of the brand, ARM & HAMMER liquid laundry has grown share year-over-year in 26 consecutive quarters. Our unit dose products are gaining traction. ARM & HAMMER unit dose in the quarter grew twice the unit dose category growth rate. Our growth was driven by our bi-layer and dual chamber innovations. Growth was equally driven by base and promoted volume signaling a healthy balance. These are encouraging signs and we are really pleased with the results. ARM & HAMMER unit dose grew 40 basis points to a 3% share in the quarter. Our XTRA brand lost share in the quarter as we continue to see deep competitive discounting. Similar to what we said in Q1, we expect XTRA net sales and profits to increase year-over-year for full-year 2016. OXI laundry share was down 10 basis points year-over-year as we, like others, felt the effect of Persil's promotional activity and increased distribution. As we have said before, we are committed to OXI laundry detergent and are in this for the long haul. As you know, Henkel has plans to acquire the Sun Products company, which owns all, Wisk and Snuggle brands and competes in private label. It's too early to know the impact on the category. There are two obvious schools of thought; we may experience a disciplined competitor who competes with innovation, or the laundry category could see even more discounting. We'll have to just wait and see. Regardless of what happens, we believe our brands are important to consumers. Consumer insights leading to the right products, at the right price point will be our formula for success. Moving on to stain fighters, OXICLEAN is the leading stain fighter in the additive category. This is the second consecutive quarter that OXICLEAN share hit a 48% share, growing 2% versus last year. Now I'm going to turn my comments to cat litter. The clumping litter segment is healthy with consumption growth of 4.5%. Q2 saw a significant increase in the amount sold on deal by competitors, notably Clorox and Tidy Cat. At the same time, our amount sold on deal was significantly lower than the prior year, resulting in a pullback in share. In the end, innovation carries the day, we are very pleased with the performance of our new premium priced CLUMP & SEAL MICROGUARD. And while we're on the topic of innovation, I would like to acknowledge that ARM & HAMMER CLUMP & SEAL litter received the prestigious 2016 Nielsen Innovation Award for food and household products. CLUMP & SEAL was selected from a field of 3,500 new product launches over a two year period. Innovation is the key to long-term organic growth and we continue to focus on litter innovation. Now, let's talk about vitamins. The overall VMS category continues to show steady growth, up 3%. The gummy segment of VMS grew at 15% in Q2. Let me break that down for you, the adult gummy segment grew 21%, while the kids gummy segment declined 4%. So vitamins is a good news story for us. Both VITAFUSION and little L'il Critters grew in the quarter. VITAFUSION adult gummy consumption grew 9% and L'il Critters children's gummy also recorded positive growth of 40 basis points. Most notable, our combined points of distribution for our vitamin business grew 5% year-on-year, reflecting continued distribution gains. Our strong quarter was the result of new item introductions, expanded distribution of existing SKUs and the quality issues that we experienced last year are behind us. In adult and children's gummy vitamins category, VITAFUSION and L'il Critters are the number one brands, with shares of 31% and 32% respectively. Adult gummies is where we are putting our focus. It is underdeveloped and will be the source of future growth for us. Remember when we bought the business, out of the entire adult VMS category, only 3% was in the gummy form. Today, it is 9%. The last category I want to address is dry shampoo. This category grew 28% in Q2 after growing 26% in Q1. The category in the U.S. is now nearly $100 million with the potential to be a $300 million category, if we match the historical category growth experienced in the UK where the product originated. BATISTE is the number one brand in the U.S. with a 22.3% share. BATISTE was the fastest growing brand in the category and BATISTE original dry shampoo is now the fastest turning SKU in the category. BATISTE global net sales will cross $100 million this year for us, making it the number one dry shampoo brand globally and the BATISTE brand is expected to be one of our fastest-growing brands in the future. Next up is Rick to give you details of our second quarter results and the outlook for Q3 and the full year. Richard A. Dierker - Chief Financial Officer & Executive Vice President: Thank you, Matt, and good morning, everybody. I'll start with EPS. Second quarter reported EPS was $0.85 per share, compared to an adjusted $0.73 in 2015, up 16.4%. The $0.85 was better than our $0.79 outlook, largely due to our organic revenue beat and gross margin expansion beat. Netted in that $0.85 is a penny or a 1.4% drag from currency year-over-year. Reported revenues were up 3.6% to $877 million, organic sales were 3.7%, exceeding our Q2 outlook of approximately 2% to 3%. Our organic sales beat was driven by our Consumer business, both Domestic and International. This may surprise some of you who track our consumption reports every few weeks, the Nielsen and IRI numbers are a barometer of consumption growth, the difference is unmeasured channels. I want to remind everyone about our strength in club and the growing strength of our online business. For example, you read in the release that online sales for our vitamin business doubled. So third-party consumption reporting is directional but doesn't give the whole picture. Now, let's review the segments. Consumer Domestic's organic sales increased by 4.4% driven by VITAFUSION Gummy Vitamins, Batiste Dry Shampoo, OXICLEAN additives and partially offset by KABOOM cleaners. We continue to expect full-year organic sales to be approximately 3% for the Domestic business. International organic growth was up an impressive 7.4%, driven largely by higher sales in Australia, Mexico and Canada. We are raising our expectation for the full-year organic growth from approximately 5% to 6% to approximately 7% to 8% for the International business. For our Specialty Products division, organic sales were down 7.7%. Milk prices are still relatively low as there is an oversupply globally. And as a result, U.S. exports, which historically have been around 15% plus of U.S. production, are now around 10%. We are lowering our expectations for the full-year for the SPD division to be down 4% to 5%. We like this business but we do experience these cycles from time to time. Turning now to gross margin, our reported second quarter gross margin was 46.5%, a 250 basis point increase from a year ago, which was quite a bit better than we originally expected, largely due to continued improvements in vitamin manufacturing, greater distribution efficiencies and higher Personal Care sales. Since we spent quite a bit of time last quarter on gross margin, I'd like to breakout the detail now for the quarter improvement versus year ago. I will do the same thing for our full-year gross margin outlook in a few minutes. Q2 gross margin benefited from lower commodities worth 70 basis points. Productivity programs, lower manufacturing costs, which include the absence of vitamin startup cost, together is worth 130 basis points. Price volume mix is worth 60 basis points, as we had higher Personal Care organic sales, up almost 8% versus a year ago. And in general, we had a low level of promotion across the portfolio. Finally, we had 20 basis points from the higher margin acquired businesses offset by a 30 basis point drag from currency. Moving to marketing, we increased marketing spend by 3.8% year-over-year. Marketing as a percent of revenue was consistent with 2015 at 13.7%. SG&A as a percentage of net sales was 12.8%, an 80 basis point decrease from the prior year on a reported basis. Remember in 2015 we had a pension settlement charge of $8.9 million, so on an adjusted basis, SG&A was up 30 basis points, in line with our full year expectations. Now to operating profit, the reported operating margin for the quarter was 20%, which is 320 basis points higher than the prior year on a reported basis and 220 basis points better on an adjusted basis, largely driven by the gross margin improvement. Other expense was $6.8 million for the quarter. Next our income taxes, our effective rate for the quarter is 34.7%, we are raising our effective tax rate forecast for the full year to 35%, largely due to geographic mix. So there is a bigger drag from tax. Turning to cash, we had a strong cash flow quarter. So on a year-to-date basis, we have generated $297 million of cash from operations, which is a $48 million increase from the same period a year ago. So in conclusion, the second quarter highlights include 3.7% organic, 16.4% EPS growth, which again equate to a 17.8% currency neutral EPS growth. Turning to the third quarter outlook, we expect Q3 organic sales growth of approximately 1% to 2%, behind stronger promotions and slower growth for our International and SPD divisions. We expect marketing as a percentage of revenue to increase, both in dollars and as a percentage of sales, as we begin to spend back our gross margin expansion. We expect third quarter earnings per share of approximately $0.92, compared to $0.90 per share a year ago, or a 2% increase year-over-year, which reflects the step up in marketing, the higher promotional activities, slightly higher SG&A due to incentive comp and a higher tax rate. And now, turning to the full year. We continue to expect organic sales growth to be 3% to 4%, which has been increased from 3% when we started the year. We posted 4.4% organic growth in the first half. And in the second half, as we plan to spend back a bit more on promotional activities, it results in lower second half organic sales growth. We will likely end up in the middle of the range. In May, we called approximately 75 basis points of gross margin expansion. And we are pleased to say that we are raising our outlook to 110 basis points of expansion. We can attribute this increase to continued improvements in vitamin manufacturing, greater distribution efficiencies offset by incremental promotional activities. I'd like to break out the detail now for the full year gross margin outlook versus year ago. For the full year, gross margin benefits from lower commodities and that's worth 60 basis points. Productivity programs, lower manufacturing costs including the absence of vitamin startup costs is worth 50 basis points. Price volume mix is worth 10 basis points as we invest a bit more in higher promotions in the back half. And finally, we forecast 20 basis points from the higher margin acquired businesses offset by a 30 basis point drag from currency. We are increasing our full year marketing expectation by 10 basis points to 12.4%, as we spend back some of the gross margin beat. Moving to SG&A, adjusting for the 2015 pension settlement charge, we are now forecasted to increase by 40 basis points. We had previously called 25 basis points for the increase. The higher SG&A rate is due to significantly higher medical cost and higher incentive comp. So now we expect 60 basis points of operating margin expansion for the full year. Next is income tax. As I mentioned before, we now expect 35% for the full year, so it's about 30 basis points greater than our previous outlook. In terms of EPS, we dropped the low end of the range and are now targeting 8% to 9% of adjusted EPS growth, despite the incremental spending on marketing and promotion as well as the higher tax rate. We now expect $640 million of operating cash flow, which is $10 million better than our previous outlook of $630 million. We continue to expect $55 million of CapEx for the full year. This equates to $585 million of free cash flow, which represents 125%-plus of free cash flow conversion. Wrapping up, as you read in our earnings release today, we also announced a two-for-one stock split of our common stock. The split will increase our total shares outstanding from approximately 128.8 million to 257.6 million shares. Now, Matt and I will open it up for questions.